Mereo BioPharma Group Plc (MREO)
0.3798
+0.01
(+3.52%)
USD |
NASDAQ |
Oct 02, 16:00
0.3726
-0.01
(-1.90%)
Pre-Market: 20:00
Mereo BioPharma Group EPS Diluted (Quarterly) : -0.0437 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0437 |
| March 31, 2026 | -0.0418 |
| December 31, 2025 | -0.0461 |
| September 30, 2025 | -0.0436 |
| June 30, 2025 | -0.0925 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.0825 |
| December 31, 2024 | -0.045 |
| September 30, 2024 | -0.0984 |
| June 30, 2024 | -0.0862 |
| March 31, 2024 | -0.0639 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.007 |
| BioNTech SE | -3.799 |
| Silence Therapeutics Plc | -0.0866 |
| Autolus Therapeutics Plc | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.018M |
| Total Expenses (Quarterly) | 7.018M |
| Enterprise Value | 31.54M |
| Earnings Yield | -46.13% |
| Normalized Earnings Yield | -46.74 |